Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 10, 2012
The FDA recently approved Kalydeco, the first drug to address the underlying cause of cystic fibrosis for a small segment of the CF population. Meet two children who are still in need of a lifesaving treatment for CF.